These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27153781)

  • 1. Cross-sectional Imaging Review of Tuberous Sclerosis.
    Krishnan A; Kaza RK; Vummidi DR
    Radiol Clin North Am; 2016 May; 54(3):423-40. PubMed ID: 27153781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature.
    Adriaensen ME; Schaefer-Prokop CM; Stijnen T; Duyndam DA; Zonnenberg BA; Prokop M
    Eur J Neurol; 2009 Jun; 16(6):691-6. PubMed ID: 19236458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.
    Cheng S; Hawkins C; Taylor MD; Bartels U
    Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations.
    Jesmanas S; Norvainytė K; Gleiznienė R; Šimoliūnienė R; Endzinienė M
    Brain Dev; 2018 Mar; 40(3):196-204. PubMed ID: 29258718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thoracoabdominal imaging of tuberous sclerosis.
    Morin CE; Morin NP; Franz DN; Krueger DA; Trout AT; Towbin AJ
    Pediatr Radiol; 2018 Aug; 48(9):1307-1323. PubMed ID: 30078036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subependymal Giant Cell Astrocytoma Size Measurement in Tuberous Sclerosis Complex: Noncontrast vs Contrast-Enhanced 3-Dimensional T1-Weighted Magnetic Resonance Imaging (MRI).
    Hill BJ; Gadde JA; Palasis S
    J Child Neurol; 2019 Dec; 34(14):922-927. PubMed ID: 31424303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
    Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
    Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review.
    Chan DL; Calder T; Lawson JA; Mowat D; Kennedy SE
    Rev Neurosci; 2018 Mar; 29(3):295-301. PubMed ID: 29211682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
    Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
    Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report.
    Beaumont TL; Godzik J; Dahiya S; Smyth MD
    J Neurosurg Pediatr; 2015 Aug; 16(2):134-7. PubMed ID: 25978531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous sclerosis complex.
    Islam MP; Roach ES
    Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
    Jóźwiak S; Nabbout R; Curatolo P;
    Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous Sclerosis: Current Update.
    Wang MX; Segaran N; Bhalla S; Pickhardt PJ; Lubner MG; Katabathina VS; Ganeshan D
    Radiographics; 2021; 41(7):1992-2010. PubMed ID: 34534018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.
    Prato G; Mancardi MM; Baglietto MG; Janis S; Vercellino N; Rossi A; Consales A; Raso A; Garrè ML
    J Child Neurol; 2014 Sep; 29(9):NP54-7. PubMed ID: 24056156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
    Curatolo P
    Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
    Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
    Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
    MacKeigan JP; Krueger DA
    Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and CT scan follow-up of subependymal giant cell tumors in tuberous sclerosis complex patients.
    Adriaensen ME; Zonnenberg BA; de Jong PA
    J Clin Neurosci; 2014 Jun; 21(6):939-41. PubMed ID: 24491584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberous sclerosis: characteristics at CT and MR imaging.
    Altman NR; Purser RK; Post MJ
    Radiology; 1988 May; 167(2):527-32. PubMed ID: 3357966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex: the past and the future.
    De Waele L; Lagae L; Mekahli D
    Pediatr Nephrol; 2015 Oct; 30(10):1771-80. PubMed ID: 25533384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.